Irritable Bowel Syndrome (IBS) Recruiting Phase 2 / 3 Trials for Rifaximin (DB01220)

Also known as: Irritable Bowel Disease / IBS (Irritable Bowel Syndrome) / IBS / IBS - Irritable Bowel Syndrome / Irritable Bowel / Colitis, Mucous / Irritable Colon / Colon, Irritable / Irritable Bowel Syndrome(IBS) / Irritable Bowel Syndrome / Mucous colitis / Colitis mucous / Irritable bowel syndrome NOS / Colon spastic / Spastic colon / Irritable colon syndrome / [X]Psychogenic IBS / Functional bowel syndrome

IndicationStatusPhase
DBCOND0030069 (Irritable Bowel Syndrome (IBS))Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03613545Fecal Microbiota Transplantation for Irritable Bowel SyndromeTreatment
NCT02651740Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant DiarrheaTreatment